[Practical use of immunosuppressive and cytostatic drugs in dermatological diseases].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D003218:Condylomata Acuminata / Q000188:drug therapy; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D010212:Papilloma / Q000188:drug therapy; D010392:Pemphigus / Q000188:drug therapy; D011230:Precancerous Conditions / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D012595:Scleroderma, Systemic / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*; D014777:Virus Diseases / Q000188:drug therapy
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D015122:Mercaptopurine; D001379:Azathioprine; D005472:Fluorouracil; D008727:Methotrexate
Utilizzazione pratica dei farmaci immunosoppressori e citostatici nelle affezioni dermatologiche.